Service Information

There are billions of patients with unmet medical needs who can’t access innovative medicine; perhaps because they don’t meet the protocol of a clinical trial, or there is no trial being run in their country. Providing early access to medicines is now a key stage in most pharmaceutical companies’ market access strategy and is vital in ensuring a successful product launch.

Clinigen has unrivalled experience in supporting pharmaceutical companies by providing ethical and compliant access to their medicines outside the clinical trial environment and prior to first approval.

We have successfully managed over 250 managed access programs, so you can be confident that we’re a safe pair of hands, ensuring early access is maximised, potential pitfalls associated with access to unlicensed medicines are avoided and your reputation is secure.

How we can help Healthcare Professionals